-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KxRAcJFVZT8R6Gs5gm9jantP3V91XOw8MXCjqmvEXWp/bhF8qlfXp7QMrGFeyO+e aNxrS72O6ju0d/SxkysJ/g== 0001327529-10-000002.txt : 20100406 0001327529-10-000002.hdr.sgml : 20100406 20100405202613 ACCESSION NUMBER: 0001327529-10-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100406 DATE AS OF CHANGE: 20100405 EFFECTIVENESS DATE: 20100406 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Posit Science Corp CENTRAL INDEX KEY: 0001327529 IRS NUMBER: 270021586 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-77126 FILM NUMBER: 10732975 BUSINESS ADDRESS: STREET 1: 225 BUSH STREET, 7TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-394-3100 MAIL ADDRESS: STREET 1: 225 BUSH STREET, 7TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 D/A 1 primary_doc.xml X0603 D/A LIVE 0001327529 Posit Science Corp 225 BUSH STREET, 7TH FLOOR SAN FRANCISCO CA 94104 415-394-3100 CALIFORNIA None None Corporation true Steven Aldrich 225 Bush Street, 7th Floor San Francisco CA 94104 Executive Officer Director Jeffrey Zimman 225 Bush Street, 7th Floor San Francisco CA 94104 Executive Officer Director Michael Merzenich 225 Bush Street, 7th Floor San Francisco CA 94104 Executive Officer Director Horace Deets 225 Bush Street, 7th Floor San Francisco CA 94104 Director Paul Klingenstein 225 Bush Street, 7th Floor San Francisco CA 94104 Director Joanna Rees 225 Bush Street, 7th Floor San Francisco CA 94104 Director Other Health Care Decline to Disclose 06 true 0001327529-10-000001 2009-12-23 false true true Offering of Series D Preferred Stock ("Series D"), and the underlying shares of Common Stock issuable upon conversion of the Series D. true Issuer's Series D was issued in connection with (i) a venture capital financing; and (ii) in exchange for outstanding principal and accrued interest on convertible notes issued by the Company. 0 5231015 5231015 0 Issuer's Series D was issued in connection with (i) a venture capital financing; and (ii) in exchange for outstanding principal and accrued interest on convertible notes issued by the Company. false 27 0 0 0 false Posit Science Corp Steven Aldrich Steven Aldrich President 2010-04-05 -----END PRIVACY-ENHANCED MESSAGE-----